Open AccessA survey of healthcare workers’ recommendations about human papillomavirus vaccination
Author(s) -
Hitomi Nishioka,
Tomoko Onishi,
Taito Kitano,
Masahiro Takeyama,
Natsuko Imakita,
Kei Kasahara,
Ryuji Kawaguchi,
Jennifer Akiko Masaki,
Keiji Nogami
Publication year - 2022
Publication title -
clinical and experimental vaccine research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.958
H-Index - 11
eISSN - 2287-366X
pISSN - 2287-3651
DOI - 10.7774/cevr.2022.11.2.149
Subject(s) - vaccination , medicine , family medicine , human papillomavirus , health care , christian ministry , hpv vaccines , environmental health , hpv infection , cervical cancer , immunology , cancer , philosophy , theology , economics , economic growth
The human papillomavirus (HPV) vaccine is safe and effective for preventing HPV-related diseases. However, HPV vaccination rates in Japan are low because the "Ministry of Health, Labour and Welfare" had stopped recommending vaccination. We assessed healthcare workers' (HCWs) current recommendations regarding the HPV vaccine and how the provision of information about HPV vaccination affected their recommendations.